MapLight Therapeutics MPLT
NASDAQ MPLT
$10.02 +0.39 (+4.05%)
As of: Oct 2, 2026 · 1:41 PM EDT

MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2024 - 2025)

Updated

MapLight Therapeutics' Net Equity Issued and Repurchased came in at $1.13 million for Q4 2025, compared with $22,000 a year earlier and down 99.4% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

For FY2025, MapLight Therapeutics' Net Equity Issued and Repurchased was $200 million.

  • Going back by year, Net Equity Issued and Repurchased was $294,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 MapLight Therapeutics 463.00 Mn 463.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 198.86 Mn
Dec 31, 2024 22,000.00
API Access

MapLight Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MPLT&period=max&api_key=YOUR_API_KEY